{
    "Trade/Device Name(s)": [
        "Emit 2000 Tacrolimus Assay",
        "Emit 2000 Tacrolimus Sample Pretreatment Reagent"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K060385",
    "Predicate Device Reference 510(k) Number(s)": [
        "P970007"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MLM"
    ],
    "Summary Letter Date": "April 6, 2006",
    "Summary Letter Received Date": "February 14, 2006",
    "Submission Date": "February 10, 2006",
    "Regulation Number(s)": [
        "21CFR862.1678"
    ],
    "Regulation Name(s)": [
        "Tacrolimus test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "transplant",
        "chemistry"
    ],
    "Analyte(s)": [
        "Tacrolimus",
        "Tacrolimus metabolite"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Emit 2000 Tacrolimus Assay and Pretreatment Reagent for quantitation of tacrolimus in whole blood for transplant therapy management.",
    "Indications for Use Summary": "In vitro quantitative analysis of tacrolimus and metabolite in human whole blood as an aid in the management of tacrolimus therapy in liver and kidney transplant patients; pretreatment reagent for use with assay.",
    "fda_folder": "Clinical Chemistry"
}